|
|
|
|
| LEADER |
02020nam a2200301 u 4500 |
| 001 |
EB002010853 |
| 003 |
EBX01000000000000001173752 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
220201 r ||| eng |
| 100 |
1 |
|
|a Gartlehner, Gerald
|
| 245 |
0 |
0 |
|a Drug class review: Second generation antidepressants
|h Elektronische Ressource
|b final report update 4
|c Gerald Gartlehner ... [et al.] ; produced by RTI-UNC Evidence-based Practice Center, Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill
|
| 246 |
3 |
1 |
|a Second generation antidepressants
|
| 260 |
|
|
|a Portland, OR
|b Oregon Health & Science University
|c 2008, c2008
|
| 300 |
|
|
|a 1 online resource
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 710 |
2 |
|
|a Research Triangle Institute-University of North Carolina Evidence-based Practice Center
|
| 710 |
2 |
|
|a Cecil G. Sheps Center for Health Services Research
|
| 710 |
2 |
|
|a Oregon Health & Science University
|b Evidence-based Practice Center
|
| 710 |
2 |
|
|a Oregon Health & Science University
|
| 710 |
2 |
|
|a Drug Effectiveness Review Project
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Drug class reviews
|
| 500 |
|
|
|a Title from PDF title page (viewed July 20, 2011)
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK47146
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Axis I psychiatric disorders such as depressive disorder, anxiety disorder, adjustment disorder, and premenstrual disorders are serious disabling illnesses. Newer treatments for these disorders include selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, and other second-generation drugs. The purpose of this review is to evaluate the comparative evidence on benefits and harms of these medications in people with depression to help policymakers and clinicians make informed choices about the use of selective serotonin reuptake inhibitors and newer antidepressants
|